End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.36 CNY | -1.18% | -2.79% | -17.96% |
Apr. 24 | Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
Apr. 23 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.18B 164M | Sales 2025 * | 1.37B 190M | Capitalization | 8.69B 1.2B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 7.34 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.33 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 856 |
Yield 2024 * |
1.77% | Yield 2025 * |
1.89% | Free-Float | 57.71% |
1 day | -0.12% | ||
1 week | -1.63% | ||
Current month | -1.86% | ||
1 month | +2.79% | ||
3 months | -7.14% | ||
6 months | -25.85% | ||
Current year | -16.98% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 60 | 06-06-10 |
Li Ji
DFI | Director of Finance/CFO | 43 | 23-04-23 |
Shu Jie Liang
BRD | Director/Board Member | 58 | 06-04-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 60 | 06-06-10 |
Shu Jie Liang
BRD | Director/Board Member | 58 | 06-04-10 |
Yu Lin Chen
BRD | Director/Board Member | 79 | 06-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +5.31% | - | |
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 8.36 | -1.18% | 7 298 691 |
24-05-20 | 8.46 | -0.12% | 8,273,050 |
24-05-17 | 8.47 | +0.24% | 8,640,500 |
24-05-16 | 8.45 | -0.47% | 7,905,005 |
24-05-15 | 8.49 | -1.74% | 9,040,900 |
End-of-day quote Shenzhen S.E., May 19, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.98% | 1.2B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 002038 Stock